The cardiologist Alexander Gold has become chief medical officer of Laboratoris Sanifit SL in Spain and president of the company’s US subsidiary in San Diego, California. A former executive at AstraZeneca Plc and development leader for the antiplatelet therapy Brilinta, Dr Gold will oversee Sanifit’s lead asset, a treatment for patients with cardiovascular diseases linked to calcification.
Dr Gold has held management positions at Portola Pharmaceuticals Inc and Reata Pharmaceuticals Inc, and is an adjunct professor at the Stanford University School of Medicine.
Sanifit announced the appointment on 14 December 2017.
Copyright 2018 Evernow Publishing Ltd